Manufacturer of complex molecular intermediates intended for pharmaceutical synthesis and drug development purposes. The company offers asymmetric catalysis, chiral induction, enzyme catalysis, and salting-out crystallization technologies to support the production of high-barrier, high-difficulty active pharmaceutical ingredients and intermediates, serving global pharmaceutical companies to accelerate new drug development, enhance synthesis efficiency, and ensure scalable, quality-controlled manufacturing across clinical and commercial stages.